ClinicalTrials.Veeva

Menu

Congenital Heart Defects and NIRS

P

Petja Fister, MD, PhD

Status

Completed

Conditions

Heart Defects, Congenital

Study type

Observational

Funder types

Other

Identifiers

NCT03411512
NIRS CHD1

Details and patient eligibility

About

Congenital Heart Defects and NIRS

Full description

Brain, kidney and intestinal tissue oxygenation in newborns with congenital heart defects assessed by near-infrared spectroscopy.

Enrollment

65 patients

Sex

All

Ages

1 day to 4 weeks old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Investigators included term newborns with critical structural CHD (of different types) who required surgical or transcatheter procedure in the first year of life. CHD were diagnosed by pediatric cardiologist by clinical examination and echocardiography.

Exclusion criteria

The exclusion criteria were pulmonary or neurological disease, perinatal asphyxia, acute illness, prematurity and congenital abnormality other than CHD.

Trial design

65 participants in 2 patient groups

CHD
Description:
Newborns with structural congenital heart defects. The exclusion criteria were pulmonary or neurological disease, perinatal asphyxia, acute illness, prematurity and congenital abnormality other than CHD.
Healthy controls
Description:
The control group comprised of healthy matched newborns without a diagnosed CHD.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems